Colorectal Cancer
3,658
525
704
1,765
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
416 trials with published results (11%)
Research Maturity
1765 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.6%
278 terminated out of 3658 trials
86.4%
-0.2% vs benchmark
9%
337 trials in Phase 3/4
24%
416 of 1765 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1765 completed trials
Clinical Trials (3658)
Telerehabilitation in Cancer Patients: Optimization of Prehabilitation and Rehabilitation Following Colorectal Resection
Complete Closure After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
A Study of MGC026 in Participants With Advanced Solid Tumors
Advanced Endo-therapeutic Procedure : Registry-based Observational Study
Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Evaluation for NCI Surgery Branch Clinical Research Protocols
Shield Post-Approval Study Protocol
A Study of IOV-5001 in Adults With Advanced Solid Tumors
Radiogenomic Profiling of Dendritic Cells and Macrophages to Predict Recurrence in Colorectal Liver Metastasis
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease